Health & Wellness FDA Approves GE HealthCare’s Revolutionary PET Imaging Radiotracer, Flurpiridaz F-18 Sep 28, 2024 The FDA approves GE Healthcare's Flurpiridaz F-18 for detecting coronary artery disease. The radiotracer promises to advance nuclear imaging technology.
